Evidence map›Paper›PMID 23746969›Full record

ArticleCell stem cell2013

The other face of ROS: a driver of stem cell expansion in colorectal cancer.

Pier Giuseppe Pelicci, Paola Dalton, Marco Giorgio

Open access · bronzeAbstract readComment
PubMed Publisher
In one paragraph

Article in Cell stem cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Relationship between theOncotarget · 2017
    Article
  8. ROS in gastrointestinal inflammation: Rescue Or Sabotage?British journal of pharmacology · 2017
    Review
  9. Review
  10. Manganese-superoxide dismutase (Mn-SOD) overexpression is a common event in colorectal cancers with mitochondrial microsatellite instability.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Pier Giuseppe PelicciDepartment of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy. piergiuseppe.pelicci@ieo.eu
Paola Dalton
Marco Giorgio
European Institute of Oncology · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

APC mutations causing Wnt activation are commonly found in colorectal cancer, but downstream pathways that facilitate tumorigenesis are unclear. In this issue of Cell Stem Cell, Myant et al. (2013) show that Rac1 activation is required for Wnt-driven Lgr5+ intestinal stem cell transformation through ROS production and NF-kB activation.

Indexed as

AnimalsColorectal NeoplasmsIntestine, SmallNeuropeptidesNF-kappa Brac1 GTP-Binding ProteinReactive Oxygen SpeciesStem CellsWnt ProteinsNeuropeptidesNF-kappa Brac1 GTP-Binding ProteinRac1 protein, mouseReactive Oxygen SpeciesWnt Proteins

Identifiers

PMID23746969
OpenAlexW2018647809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.